Brazil Active Pharmaceutical Ingredients Market Size & Outlook
Brazil active pharmaceutical ingredients market, 2018-2030 (US$M)
Related Markets
Brazil active pharmaceutical ingredients market highlights
- The Brazil active pharmaceutical ingredients market generated a revenue of USD 4,690.3 million in 2023 and is expected to reach USD 7,332.4 million by 2030.
- The Brazil market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, synthetic was the largest revenue generating type of synthesis in 2023.
- Synthetic is the most lucrative type of synthesis segment registering the fastest growth during the forecast period.
Active pharmaceutical ingredients market data book summary
| Market revenue in 2023 | USD 4,690.3 million |
| Market revenue in 2030 | USD 7,332.4 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Synthetic |
| Fastest growing segment | Synthetic |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Synthetic, Biotech |
| Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.0% of the global active pharmaceutical ingredients market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 3,384.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Active Pharmaceutical Ingredients Market Scope
Active Pharmaceutical Ingredients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil active pharmaceutical ingredients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 70.54% in 2023. Horizon Databook has segmented the Brazil active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is gradually gaining global attention for its API manufacturing capacity through locally hosted summits, such as those organized by BRICS. Brazil currently dominates the market in this region. However, the country’s exports are limited at USD 6.4 billion. It relies on imports for nearly 95% of its pharmaceutical raw materials.
. For instance, in September 2022, Biotimize started a fundraising round for establishing first biological CDMO in Brazil. In October 2022, Similis Bio signed a licensing deal for biosimilar assets with Blau Farmacêutica.
Reasons to subscribe to Brazil active pharmaceutical ingredients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil active pharmaceutical ingredients market databook
-
Our clientele includes a mix of active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Brazil active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)
Brazil Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
